These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 19190878

  • 1. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.
    Shahgholi E, Vosough P, Sotoudeh K, Arjomandi K, Ansari S, Salehi S, Faranoush M, Ehsani MA.
    Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS, Mokhtar GM, El-Laboudy MA, Khalifa AS.
    Acta Haematol; 2006 Dec; 115(1-2):46-52. PubMed ID: 16424649
    [Abstract] [Full Text] [Related]

  • 5. A comparison of intravenous immunoglobulin (2 g/kg totally) and single doses of anti-D immunoglobulin at 50 μg/kg, 75 μg/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience.
    Alioglu B, Ercan S, Tapci AE, Zengin T, Yazarli E, Dallar Y.
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):505-9. PubMed ID: 23470649
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children.
    Ancona KG, Parker RI, Atlas MP, Prakash D.
    J Pediatr Hematol Oncol; 2002 Oct; 24(7):540-4. PubMed ID: 12368690
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical effect of anti-D immunoglobulin in treatment of childhood immune thrombocytopenia: a Meta analysis].
    Qin W, Huang SL, Li TT.
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Oct; 19(10):1070-1076. PubMed ID: 29046203
    [Abstract] [Full Text] [Related]

  • 12. A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in Korean children.
    Son DW, Jeon IS, Yang SW, Cho SH.
    J Pediatr Hematol Oncol; 2008 Aug; 30(8):598-601. PubMed ID: 18799936
    [Abstract] [Full Text] [Related]

  • 13. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial.
    Benesch M, Kerbl R, Lackner H, Berghold A, Schwinger W, Triebl-Roth K, Urban C.
    J Pediatr Hematol Oncol; 2003 Oct; 25(10):797-800. PubMed ID: 14528103
    [Abstract] [Full Text] [Related]

  • 14. Comparison of anti-D immunoglobulin, methylprednisolone, or intravenous immunoglobulin therapy in newly diagnosed pediatric immune thrombocytopenic purpura.
    Celik M, Bulbul A, Aydogan G, Tugcu D, Can E, Uslu S, Dursun M.
    J Thromb Thrombolysis; 2013 Feb; 35(2):228-33. PubMed ID: 22956408
    [Abstract] [Full Text] [Related]

  • 15. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
    Kumar M, Vik TA, Johnson CS, Southwood ME, Croop JM.
    Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
    [Abstract] [Full Text] [Related]

  • 16. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
    Blanchette V, Imbach P, Andrew M, Adams M, McMillan J, Wang E, Milner R, Ali K, Barnard D, Bernstein M.
    Lancet; 1994 Sep 10; 344(8924):703-7. PubMed ID: 7915773
    [Abstract] [Full Text] [Related]

  • 17. Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity.
    Güngör T, Arman Bilir Ö, Koşan Çulha V, Güngör A, Kara A, Azık FM, Yaralı HN.
    Pediatr Neonatol; 2019 Aug 10; 60(4):411-416. PubMed ID: 30470618
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
    Ou CY, Hsieh KS, Chiou YH, Chang YH, Ger LP.
    Acta Paediatr Taiwan; 2006 Aug 10; 47(5):226-31. PubMed ID: 17352309
    [Abstract] [Full Text] [Related]

  • 19. Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.
    Blackhouse G, Xie F, Levine MA, Campbell K, Assasi N, Gaebel K, O'Reilly D, Tarride J, Goeree R.
    J Popul Ther Clin Pharmacol; 2012 Aug 10; 19(2):e166-78. PubMed ID: 22580389
    [Abstract] [Full Text] [Related]

  • 20. Comparison between IV immune globulin (IVIG) and anti-D globulin for treatment of immune thrombocytopenia: a randomized open-label study.
    Eghbali A, Azadmanesh P, Bagheri B, Taherahmadi H, Sadeghi Sedeh B.
    Fundam Clin Pharmacol; 2016 Aug 10; 30(4):385-9. PubMed ID: 26991138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.